MPM
CLB icon

Meritage Portfolio Management’s Core Laboratories CLB Stock Holding History

Meritage Portfolio Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-23,067
Closed -$3.5M – 201
2013
Q2 		$3.5M Buy
+23,067
New +$3.27M 0.5% 100

Other funds holding CLB

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Meritage Portfolio Management's CLB Position: Q3 2013 in Review

Meritage Portfolio Management sold out of Core Laboratories (CLB) in Q3 2013, closing a stake of 23,067 shares — an estimated $3.5M sold.

Meritage Portfolio Management first reported a position in CLB in Q2 2013 and held it in 1 quarter. The position peaked at $3.5M in Q2 2013. 302 funds tracked by Wall St. Rank hold CLB as of Q3 2013.

  • Meritage Portfolio Management reported no remaining Core Laboratories position as of Q3 2013 after selling out during the quarter.
  • Meritage Portfolio Management sold 23,067 Core Laboratories shares in Q3 2013, an estimated $3.5M.
  • Meritage Portfolio Management first reported a position in Core Laboratories in Q2 2013 and held it in 1 quarter.
  • Meritage Portfolio Management's Core Laboratories position peaked at $3.5M in Q2 2013.
  • 302 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2013.

Based on Meritage Portfolio Management's 13F filing for Q3 2013, filed 31 Oct 2013.